[Breast cancer invasiveness: how does it emerge?].
Hashimoto
Shigeru
S
hashimot@obi.or.jp
Onodera
Yasuhito
Y
D000089982:ADP-Ribosylation Factor 6; D020727:ADP-Ribosylation Factors / Q000502:physiology; D048868:Adaptor Proteins, Signal Transducing / Q000502:physiology; D000818:Animals; D001943:Breast Neoplasms / Q000098:blood supply / Q000473:pathology*; D015820:Cadherins / Q000235:genetics / Q000502:physiology; D002448:Cell Adhesion / Q000235:genetics; D005260:Female; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000502:physiology; D016023:Integrins / Q000502:physiology; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000235:genetics; D051419:Paxillin / Q000502:physiology; D011485:Protein Binding; D014158:Transcription, Genetic
D000089982:ADP-Ribosylation Factor 6; C117891:ASAP1 protein, human; D048868:Adaptor Proteins, Signal Transducing; D015820:Cadherins; D051793:Hypoxia-Inducible Factor 1; D016023:Integrins; D051419:Paxillin; D020727:ADP-Ribosylation Factors